Halozyme Therapeutics
HALO
#2173
Rank
NZ$12.44 B
Marketcap
$101.01
Share price
1.35%
Change (1 day)
73.08%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.86

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $3.02. In 2022 the company made an earnings per share (EPS) of $2.57 a decrease over its 2021 EPS that were of $4.95.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.8611.48%
2022$2.57-48.07%
2021$4.95196.88%
2020$1.67-292%
2019-$0.87-9.09%
2018-$0.95-237.5%
2017$0.69-149.38%
2016-$1.41211.54%
2015-$0.45-52.73%
2014-$0.95-24.66%
2013-$1.2748.98%
2012-$0.85145%
2011-$0.35-64.29%
2010-$0.97-17.65%
2009-$1.189.68%
2008-$1.0893.75%
2007-$0.5633.33%
2006-$0.42-4%
2005-$0.43-3.85%
2004-$0.45-13.33%
2003-$0.5283.59%
2002-$0.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.33-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.42 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.88 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.23 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.52 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$24.44 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA